6
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Suppression by Anticancer Agents of Reactive Oxygen Generation from Polymorphonuclear Leukocytes

&
Pages 39-53 | Received 24 Mar 1995, Published online: 07 Jul 2009
 

Abstract

The influence of anticancer agents on signal transduction for reactive oxygen generation was examined in polymorphonuclear leukocytes (PMN). Inositol 1,4,5-trisphosphate and diacyl glycerol levels in formyl-methionyl-leucyl-phenylalanine (FMLP)-stimulated PMN were decreased by cis-diammine-dichloroplatinum (CDDP), 5-fluorouracil (5-FU), 137Cs, and peplomycin (PLM, a bleomcin analog) in this order. Intracellular calcium ([Ca2+]i) level and protein kinase C (PKC) activity in the membrane after phorbol myristate acetate (PMA) stimulation were decreased by 5-FU and CDDP but not by 137Cs and, in contrast, were increased by PLM. The level of [Ca 2+]i was decreased by 8 h treatment with 5-FU and CDDP. 5-FU and CDDP inhibited tyrosine phoshorlation of 83-kDa and 115-kDa proteins, however 137Cs did not inhibit their phos-phorylation and PLM enhanced the tyrosine phosphorylation. Short term (≤ 4 h) treatment with PLM, 5-FU and CDDP enhanced respiratory burst of PMN, whereas long term (8 h) treatment, as well as radiation, suppressed reactive oxygen generation from PMN in a dose dependent manner. Genistein supressed chemiluminescence in 5-FU-, CDDP-, and 137Cs-pretreated PMN to a greater extent than it did in PLM-pretreated PMN, however near suppression of chemiluminescence by staurosporine, 4-bromophenyl bromide and methionine was observed in PMN pre-treated with these agents. In conclusion, these results indicate that long term treatment of PMN with 5-FU and CDDP inhibit respiratory burst, suppressing intracellular calcium mobilization, PKC translocation and tyrosine kinase activation, in adverse, short term treatment with PLM enhances PKC translocation and tyrosine kinase activation, but inhibits myeloperoxidase (MPO) activity, and radiation causes weak inhibition of signal transduction for respiratory burst.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.